IA
XLRN

IFP Advisors’s Acceleron Pharma XLRN Stock Holding History

IFP Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,372
Closed -$237K – 3550
2021
Q3 		$237K Sell
1,372
-35
-2% -$4.58K ﹤0.01% 878
2021
Q2 		$178K Sell
1,407
-6
-0.4% -$757 ﹤0.01% 961
2021
Q1 		$192K Buy
1,413
+191
+16% +$24.7K ﹤0.01% 856
2020
Q4 		$156K Buy
1,222
+159
+15% +$18.6K 0.01% 917
2020
Q3 		$118K Buy
+1,063
New +$106K 0.01% 914
2019
Q1 		– Sell
-6
Closed – – 3700
2018
Q4 		$0 Hold
6
– – ﹤0.01% 3984
2018
Q3 		$0 Hold
6
– – ﹤0.01% 4094
2018
Q2 		$0 Hold
6
– – ﹤0.01% 4135
2018
Q1 		$0 Hold
6
– – ﹤0.01% 3871
2017
Q4 		$0 Hold
6
– – ﹤0.01% 4207
2017
Q3 		$0 Hold
6
– – ﹤0.01% 4276
2017
Q2 		$0 Hold
6
– – ﹤0.01% 4271
2017
Q1 		$0 Sell
6
-15
-71% -$395 ﹤0.01% 4196
2016
Q4 		$1K Hold
21
– – ﹤0.01% 3885
2016
Q3 		$1K Buy
21
+6
+40% +$199 ﹤0.01% 3809
2016
Q2 		$1K Buy
+15
New +$488 ﹤0.01% 3726
2016
Q1 		– Sell
-32
Closed -$2K – 3690
2015
Q4 		$2K Buy
+32
New +$1.15K ﹤0.01% 3399

IFP Advisors's XLRN Position: Q4 2021 in Review

IFP Advisors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,372 shares — an estimated $237K sold.

IFP Advisors first reported a position in XLRN in Q4 2015 and held it in 17 quarters. The position peaked at $237K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • IFP Advisors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • IFP Advisors sold 1,372 Acceleron Pharma shares in Q4 2021, an estimated $237K.
  • IFP Advisors first reported a position in Acceleron Pharma in Q4 2015 and held it in 17 quarters.
  • IFP Advisors's Acceleron Pharma position peaked at $237K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on IFP Advisors's 13F filing for Q4 2021, filed 12 Jan 2022.